Assessing How Normal Variations in CT Scanning Affects Its Interpretation
NCT03038568 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 169
Last updated 2026-04-22
Summary
The purpose of the study is to see how measurements of tumor differences vary with slight changes in CT scan parameters. Reproducible radiomic features can be extracted for abdominal tumors, and specifically colorectal liver metastases, imaged with clinical CT scanners even in the setting of variable scan parameters and variable contrast timing. Participants will be consented to undergo an additional CT of their abdomen.
Conditions
- Colorectal Cancer Metastatic
Interventions
- DIAGNOSTIC_TEST
-
CT scan
Patients with colorectal liver metastases scheduled for abdominopelvic CECT will be consented to undergo an additional CT of their abdomen (termed add-on CT) within 15 seconds, before or after, their clinical portal venous phase CT (PV CT), which is performed at a fixed delay of 80 seconds at our institution.
Sponsors & Collaborators
-
Queen's University
collaborator OTHER -
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Kinh Gian Richard Do, MD, PhD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-27
- Primary Completion
- 2027-01-27
- Completion
- 2027-01-27
Countries
- United States
Study Locations
More Related Trials
-
Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics
NCT02144311 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial
NCT00316901 ·Status: COMPLETED ·Phase: PHASE2
-
Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors
NCT00598741 ·Status: COMPLETED ·Phase: NA
-
Improving Clinical PET/CT Image Quality in Retrospectively Reconstructed Breath-Hold Images
NCT01109953 ·Status: TERMINATED
-
Somatostatin Receptor PET/CT in SSTR-Related Disease Patients
NCT06690957 ·Status: RECRUITING
-
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular Carcinoma
NCT03636607 ·Status: WITHDRAWN ·Phase: NA
-
PET Respiratory Gating to Detect Hepatic Metastasis in Patients With Colon Cancer
NCT01401309 ·Status: COMPLETED
-
Imaging Correlates of Renal Cell Carcinoma Biological Features
NCT01665703 ·Status: COMPLETED ·Phase: NA
-
An Investigational Scan (MR DENSE) in Detecting Early Chemotherapy-Related Liver Injury Before Surgery in Patients With Resectable Colorectal Liver Metastases
NCT05059717 ·Status: WITHDRAWN ·Phase: NA
-
CD70-targeted immunoPET Imaging of Kidney Cancer
NCT06680089 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT
NCT00823810 ·Status: TERMINATED ·Phase: NA
-
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence
NCT05856409 ·Status: RECRUITING
-
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
NCT04017104 ·Status: UNKNOWN
-
Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer
NCT02370290 ·Status: COMPLETED
-
Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
NCT00351728 ·Status: COMPLETED
-
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer
NCT05637034 ·Status: UNKNOWN ·Phase: NA
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
NCT05673031 ·Status: RECRUITING
-
Volumetric Analysis in the Assessment of Therapy Response by CT
NCT00582751 ·Status: COMPLETED
-
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
NCT04499365 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
64Cu/68Ga Labelled EB-ss-CPT PET/CT Scan in Colorectal Cancer
NCT05891028 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion
NCT05879497 ·Status: UNKNOWN ·Phase: PHASE2
-
Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection
NCT01575951 ·Status: COMPLETED ·Phase: NA
-
CT Assessment of BMI in Endometrial Cancer Patients
NCT03962140 ·Status: COMPLETED
-
Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms
NCT03288597 ·Status: UNKNOWN